76 related articles for article (PubMed ID: 18939498)
21. Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
McElrath MJ; Corey L; Greenberg PD
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S69-72. PubMed ID: 7865336
[TBL] [Abstract][Full Text] [Related]
22. Hitting HIV where it hurts: an alternative approach to HIV vaccine design.
Altfeld M; Allen TM
Trends Immunol; 2006 Nov; 27(11):504-10. PubMed ID: 16997629
[TBL] [Abstract][Full Text] [Related]
23. Progress towards an AIDS mucosal vaccine: an overview.
Yuki Y; Nochi T; Kiyono H
Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
[TBL] [Abstract][Full Text] [Related]
24. Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection.
Mwimanzi P; Hasan Z; Tokunaga M; Gatanaga H; Oka S; Ueno T
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):422-7. PubMed ID: 21093412
[TBL] [Abstract][Full Text] [Related]
25. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
[TBL] [Abstract][Full Text] [Related]
26. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
[TBL] [Abstract][Full Text] [Related]
27. The role of CD8+ T-cell response in HIV infection.
Benito JM; López M; Soriano V
AIDS Rev; 2004; 6(2):79-88. PubMed ID: 15332430
[TBL] [Abstract][Full Text] [Related]
28. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
[TBL] [Abstract][Full Text] [Related]
29. Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS.
Ahlers JD; Belyakov IM
Trends Immunol; 2010 Mar; 31(3):120-30. PubMed ID: 20089450
[TBL] [Abstract][Full Text] [Related]
30. AIDS vaccine development: the long and winding road.
Garber DA; Feinberg MB
AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
[TBL] [Abstract][Full Text] [Related]
31. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
Ahlers JD; Belyakov IM
Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
[TBL] [Abstract][Full Text] [Related]
32. Viral evolution and challenges in the development of HIV vaccines.
Barouch DH; Letvin NL
Vaccine; 2002 Dec; 20 Suppl 4():A66-8. PubMed ID: 12477431
[TBL] [Abstract][Full Text] [Related]
33. [Selection of HIV escape mutants by CTL and adaptation of HIV to HLA class I].
Takiguchi M
Uirusu; 2009 Dec; 59(2):145-53. PubMed ID: 20218323
[TBL] [Abstract][Full Text] [Related]
34. HIV escape and attenuation by cytotoxic T lymphocytes.
Leslie AJ; Goulder P
Curr Opin HIV AIDS; 2006 Jan; 1(1):34-9. PubMed ID: 19372781
[TBL] [Abstract][Full Text] [Related]
35. Will we be able to 'spot' an effective HIV-1 vaccine?
Yang OO
Trends Immunol; 2003 Feb; 24(2):67-72. PubMed ID: 12547502
[TBL] [Abstract][Full Text] [Related]
36. Evolution and plasticity of CTL responses against HIV.
Autran B; Hadida F; Haas G
Curr Opin Immunol; 1996 Aug; 8(4):546-53. PubMed ID: 8794018
[TBL] [Abstract][Full Text] [Related]
37. Amantadine Surface-Modified Silver Nanorods Improves Immunotherapy of HIV Vaccine Against HIV-Infected Cells.
Li W; Balachandran YL; Hao Y; Hao X; Li R; Nan Z; Zhang H; Shao Y; Liu Y
ACS Appl Mater Interfaces; 2018 Aug; 10(34):28494-28501. PubMed ID: 30085647
[TBL] [Abstract][Full Text] [Related]
38. Boot Camp Emphasizes Industry-Style Approach to HIV Vaccine Development.
Kresge KJ
IAVI Rep; 2015; 19(4):18-9. PubMed ID: 26841637
[No Abstract] [Full Text] [Related]
39. Search for HIV vaccine faces setback.
Connor S
BMJ; 1995 Mar; 310(6981):691. PubMed ID: 7711533
[No Abstract] [Full Text] [Related]
40. [Current status of HIV vaccine development].
Seki S; Matano T
Nihon Rinsho; 2008 Oct; 66(10):1965-9. PubMed ID: 18939498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
